Published in Ann Hematol on April 01, 1993
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med (1999) 3.13
Isodisomy of chromosome 7 in a patient with cystic fibrosis: could uniparental disomy be common in humans? Am J Hum Genet (1989) 2.43
Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet (2000) 2.39
EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol (1991) 2.35
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet (1983) 2.15
Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med (1984) 1.92
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Can we rely on the family history? Am J Med Genet (1998) 1.61
Laparoscopic accessory splenectomy for recurrent idiopathic thrombocytopenic purpura and hemolytic anemia. Surg Endosc (2000) 1.61
Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics (1987) 1.59
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol (1994) 1.48
Lymphoma and systemic sclerosis--an uncommon association or possible coincidence of two disorders with a fatal outcome. Eur J Haematol (1997) 1.42
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer (1992) 1.42
Cleft lip and palate, pili torti, malformed ears, partial syndactyly of fingers and toes, and mental retardation: a new syndrome? J Med Genet (1987) 1.40
Hyperphosphatasemia in infantile GM1 gangliosidosis: possible association with microscopic bone marrow osteoblastosis. J Pediatr (1990) 1.40
Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem (1999) 1.35
Lymphocyte-hepatic stellate cell proximity suggests a direct interaction. Clin Exp Immunol (2007) 1.35
Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res (1989) 1.33
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul (1990) 1.22
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat (2012) 1.21
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology (2000) 1.19
Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet (1997) 1.18
Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood (2000) 1.13
Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J (Clin Res Ed) (1982) 1.13
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. J Clin Invest (1981) 1.11
Homozygosity mapping of achromatopsia to chromosome 2 using DNA pooling. Hum Mol Genet (1997) 1.11
Asplenia and polysplenia syndromes with abnormalities of lateralisation in a sibship. J Med Genet (1981) 1.11
Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am J Hum Genet (1995) 1.10
Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol (2001) 1.10
Multiple mutations in a specific gene in a small geographic area: a common phenomenon? Am J Hum Genet (1996) 1.08
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum (2001) 1.08
Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver Int (2004) 1.07
Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel. Hum Genet (1996) 1.07
Localization of the Krabbe disease gene (GALC) on chromosome 14 by multipoint linkage analysis. Am J Hum Genet (1993) 1.07
High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med (1987) 1.07
The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells. Exp Cell Res (1985) 1.06
Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. J Clin Invest (1989) 1.06
Molecular genetics of metachromatic leukodystrophy. Hum Mutat (1994) 1.05
Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identification of an apparent case of germinal mosaicism. Am J Med Genet (1993) 1.03
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J Viral Hepat (2015) 1.02
Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leuk Lymphoma (1996) 1.02
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol (1996) 1.02
Transient neonatal diabetes mellitus in a child with invdup(6)(q22q23) of paternal origin. Eur J Hum Genet (1998) 1.01
Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol (2001) 1.00
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. Thromb Res (1982) 1.00
Hunter's syndrome: activity of iduronate sulfate sulfatase in the serum of pregnant heterozygotes. N Engl J Med (1984) 1.00
Intracranial hemorrhage in patients with hemophilia. Neurosurgery (1986) 1.00
Krabbe disease: increased incidence in a highly inbred community. Am J Med Genet (1985) 0.99
Latent viruses and Bell's palsy in children. Eur Neurol (1978) 0.97
The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost (1984) 0.97
Hypoglycemia in patients with renal failure. Ren Fail (2000) 0.97
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest (1984) 0.96
Identification of a prevalent founder mutation in an Israeli Muslim Arab village confirms the role of PRCD in the aetiology of retinitis pigmentosa in humans. J Med Genet (2010) 0.94
Both recessive and dominant forms of anhidrotic/hypohidrotic ectodermal dysplasia map to chromosome 2q11-q13. Am J Hum Genet (1999) 0.94
Heterozygote detection in Hunter syndrome. Am J Med Genet (1984) 0.93
High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand (2000) 0.93
A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood (1997) 0.93
On the inheritance of primary spontaneous pneumothorax. Am J Med Genet (1991) 0.92
Heterogeneity of the autosomal dominant split hand/split foot malformation. Am J Hum Genet (1995) 0.92
Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. Am J Hum Genet (1994) 0.92
The genetics of the aryl sulfatase A locus. Am J Hum Genet (1981) 0.92
Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet (1996) 0.92
Transjugular core liver biopsy with a 19-gauge spring-loaded cutting needle. Cardiovasc Intervent Radiol (1998) 0.92
Esophagitis is a major cause of upper gastrointestinal hemorrhage in the elderly. Scand J Gastroenterol (1997) 0.92
Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus. J Virol (1989) 0.92
Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood (1990) 0.92
Familial café au lait spots: a variant of neurofibromatosis type 1. J Med Genet (1995) 0.91
Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology (1999) 0.91
Machado-Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation. Eur J Hum Genet (1996) 0.90
A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23. Am J Hum Genet (1996) 0.90
The femur, fibula, ulna (FFU) complex in siblings. Clin Genet (1983) 0.90
Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase. Mol Cell Biol (1999) 0.89
Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapy. Semin Thromb Hemost (1996) 0.89
Otoacoustic emissions and brainstem evoked potentials in compound carriers of connexin 26 mutations. Hear Res (2003) 0.89
Inhibition of platelet-derived growth factor-induced mitogenesis and tyrosine kinase activity in cultured bone marrow fibroblasts by tyrphostins. Exp Cell Res (1992) 0.89
The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets. Thromb Res (1979) 0.89
Heparanase activity in cultured endothelial cells. J Cell Physiol (1991) 0.89
Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol (1997) 0.89
Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2. J Viral Hepat (2015) 0.89
The effects of a connexin 26 mutation--35delG--on oto-acoustic emissions and brainstem evoked potentials: homozygotes and carriers. Hear Res (2002) 0.89
Autosomal dominant inheritance of Klein-Waardenburg syndrome. Am J Med Genet (1992) 0.89
Metachromatic leukodystrophy in the habbanite Jews: high frequency in a genetic isolate and screening for heterozygotes. Am J Hum Genet (1980) 0.89
Syndactyly, ectodermal dysplasia, and cleft lip and palate. J Med Genet (1988) 0.88
Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy (2001) 0.87
Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool. Am J Med Genet (1994) 0.87
The saliva of the medicinal leech Hirudo medicinalis--II. Inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects. Comp Biochem Physiol C (1987) 0.87
Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Haematol (1993) 0.87
Bile salts facilitate the absorption of heparin from the intestine. Biochem Pharmacol (1983) 0.87
Production and characterization of interferon from endothelial cells. J Cell Physiol (1985) 0.87